The NHS will provide the monoclonal antibody Crysvita at 20 specialist centres across England for patients with XLH.
Roche has signed an agreement for the acquisition of Poseida Therapeutics in a deal representing a total value of up to ...
Gilead and Aelix first teamed up in 2018 for a clinical research collaboration agreement to investigate the vaccine.
The Food and Drug Administration (FDA) has approved Shorla Oncology‘s IMKELDI for the treatment of specific leukaemia cancer ...
PCI Pharma Services is a winner in the Innovation and Business Expansion categories in the 2024 Pharmaceutical Technology ...
Neonatal diabetes mellitus affects an estimated 300 individuals in the US. Credit: July Semianovich/Shutterstock. Eton ...
Shares in Roche opened 0.55% lower at market open following the news. Image credit: Shutterstock / Marlon Trottmann. Roche’s ...